
GC39160
BCI-215
Also known as (2E)-2-benzylidene-5-bromo-3-(cyclohexylamino)-3H-inden-1-one
BCI-215 is a potent and tumor cell-selective dual specificity MAPK phosphatase (DUSP-MKP) inhibitor· BCI-215 has cytotoxicity for tumor cells but not normal cells
ChemicalCAS1245792-67-9MW396.32FormulaC22H22BrNO
- CAS number
- 1245792-67-9
- Molecular weight
- 396.32
- Formula
- C22H22BrNO
- Solubility
- DMSO: 33·33 mg/mL (84·10 mM)
- InChIKey
- JGWQWVVSCQBAFC-DEDYPNTBSA-N
- Catalogue number
- GC39160
- Brand
- GLPBIO
Computed properties PubChem CID 46912328 · XLogP 5.4 · TPSA 29.1 Ų · H-bond donors 1
- XLogP
- 5.4
- TPSA
- 29.1 Ų
- H-bond donors
- 1
- H-bond acceptors
- 2
- Rotatable bonds
- 3
- Heavy atoms
- 25
SMILES C1CCC(CC1)NC\2C3=C(C=CC(=C3)Br)C(=O)/C2=C/C4=CC=CC=C4
Computed descriptors from PubChem (CID 46912328), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il